Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2016-02-26 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MOUTIERS (73600), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMA VALLEE : revenue, balance sheet and financial ratios
PHARMA VALLEE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MOUTIERS (73600),
this company of category PME
shows in 2025 a net income positive of 381 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMA VALLEE (SIREN 818741597)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
380 827 €
386 160 €
454 838 €
449 112 €
371 547 €
287 190 €
251 798 €
194 767 €
68 560 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMA VALLEE generates positive net income of 381 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 69 k€ -> 381 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
380 827 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
125.475%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.579%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
614.62
348.722
213.84
184.14
125.988
92.567
68.521
52.652
125.475
Financial autonomy
12.297
20.15
28.601
31.203
39.492
46.714
52.705
59.791
39.579
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
125.472025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+24 pts over 3 years
In 2025, the debt ratio of PHARMA VALLEE (125.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.58%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average-23 pts over 3 years
In 2025, the financial autonomy of PHARMA VALLEE (39.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 205.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
205.234
Liquidity indicators evolution PHARMA VALLEE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
170.539
216.041
251.709
222.589
260.575
293.802
289.203
342.31
205.234
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
205.232025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good-18 pts over 3 years
In 2025, the liquidity ratio of PHARMA VALLEE (205.23) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMA VALLEE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMA VALLEE is estimated at
6 049 482 €
(range 4 105 207€ - 9 492 470€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
4105k€6049k€9492k€
6 049 482 €Range: 4 105 207€ - 9 492 470€
NAF 5 année 2025
Valuation method used
Net Income Multiple
380 827 €
×
15.9x
=6 049 482 €
Range: 4 105 207€ - 9 492 471€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMA VALLEE with other companies in the same sector:
The revenue of PHARMA VALLEE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMA VALLEE profitable?
Yes, PHARMA VALLEE generated a net profit of 381 k€ in 2025.
Where is the headquarters of PHARMA VALLEE ?
The headquarters of PHARMA VALLEE is located in MOUTIERS (73600), in the department Savoie.
Where to find the tax return of PHARMA VALLEE ?
The tax return of PHARMA VALLEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMA VALLEE operate?
PHARMA VALLEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart